MediFind
Condition

Epidermolysis Bullosa Acquisita

Symptoms, Doctors, Treatments, Research & More

Condition 101

What is the definition of Epidermolysis Bullosa Acquisita?

Epidermolysis bullosa acquisita (EBA) is a rare autoimmune disorder that causes the skin to blister in response to minor injury. Common areas of blistering include the hands, feet, knees, elbows, and buttocks. It can also affect the mouth, nose, and eyes. Some affected people have other health problems such as Crohn's disease, systemic lupus erythematosus, amyloidosis, or multiple myeloma. EBA is not inherited and usually occurs in adulthood. Treatment aims to protect the skin, stop the formation of blisters, and promote healing. Immunosuppressive drugs may be used to reduce the body's autoimmune response.

What are the alternative names for Epidermolysis Bullosa Acquisita?

  • EB acquisita
  • EBA
  • Acquired epidermolysis bullosa

What are the causes for Epidermolysis Bullosa Acquisita?

The underlying cause of epidermolysis bullosa acquisita (EBA) is not known. It is thought to be an autoimmune disorder, which means that the immune system attacks healthy cells by mistake. In EBA, certain immune proteins (usually IgG autoantibodies) mistakenly target and attack a specific type of collagen (a skin protein) involved in "anchoring" the skin. In some milder cases of EBA, the immune proteins involved are thought to be IgA, rather than IgG autoantibodies. The initiating event that leads to autoantibody production is unknown.

EBA affecting several family members has been reported, suggesting a genetic component may be involved in some cases. Rarely, people with lupus, a systemic autoimmune disease, develop a generalized blistering skin disease with the features of EBA. EBA has also been associated with Crohn's disease.

What are the symptoms for Epidermolysis Bullosa Acquisita?

Symptoms of epidermolysis bullosa acquisita (EBA) usually occur in a person's 30s or 40s. The signs and symptoms can differ among affected people, and the condition has several distinct forms of onset. For example:

Non-inflammatory or mildly inflammatory EBA affecting only trauma-prone skin (the "classic" form) may cause:

  • tense, blood- or pus-filled blisters, mostly on the hands, knees, knuckles, elbows and ankles
  • mucous-membrane blisters that rupture easily
  • healing with significant scarring and small white spots (milia)

Generalized inflammatory EBA may cause:

  • widespread blisters that are not localized to trauma-prone sites
  • generalized redness and itching
  • healing with minimal scarring
The mucous membrane form of EBA may cause:
  • blisters on various mucous membranes
  • significant scarring and dysfunction
The features of the condition may change during the course of the disease or may represent two forms at the same time.

Is Epidermolysis Bullosa Acquisita an inherited disorder?

Unlike the genetic forms of epidermolysis bullosa, epidermolysis bullosa acquisita (EBA) is considered an acquired, sporadic disease. This means that it generally occurs in people with no history of the condition in their families.

There have been a couple of reports of families with more than one affected person, suggesting a genetic component may be involved. This could mean that EBA may develop in a person who is "genetically susceptible." However, the condition is not thought to be due to any specific gene(s).

Top Global Doctors

DZ
Elite
Detlef Zillikens
Luebeck, SH, DE
ES
Elite
Enno W. Schmidt
Luebeck, SH, DE
RL
Elite
Ralf J. Ludwig
Luebeck, SH, DE
TH
Elite
Takashi Hashimoto
Osaka, 27, JP
NI
Elite
Norito Ishii
Kurume, 40, JP
KB
Elite
Katja Bieber
Luebeck, SH, DE

Latest Research

Latest Advance
Study
  • Condition: Recalcitrant Pemphigoid Diseases
  • Journal: Frontiers in immunology
  • Treatment Used: Rituximab (RTX)
  • Number of Patients: 28
  • Published —
This study assessed the effectiveness and safety of rituximab (RTX) in pemphigoid (immune) diseases.

Clinical Trials

There are no recent clinical trials available for this condition. Please check back because new trials are being conducted frequently.